TCL Archive In Brief: George Vande Woude Of NCI Named PI for Litton Bionetics Basic Research Contract At Frederick September 23, 1983
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012